Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+EAMA Project

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F19%3A10400087" target="_blank" >RIV/00179906:_____/19:10400087 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11120/19:43919064

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rHUVjRrHe8" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rHUVjRrHe8</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jamda.2019.04.030" target="_blank" >10.1016/j.jamda.2019.04.030</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+EAMA Project

Popis výsledku v původním jazyce

Sarcopenia is a disease characterized by a progressive loss of skeletal muscle mass and strength and is related to physical impairment, disability, worse clinical outcomes, and mortality in all health care settings.1 An important fact is that it is also reversible, with tailored exercise and nutritional support.1,2 Sarcopenia prevalence varies widely depending on the criteria, measurement methods, and cut-off points used for its assessment1,2; to date, few studies addressed the issue of sarcopenia in hospitalized older patients, rendering it an under-recognized clinical entity.3-5 In 2015, the European Geriatric Medicine Society (EuGMS) founded the Special Interest Group on Sarcopenia, which aims to bridge the gaps between clinical practice and research (&quot;Action-Research Philosophy&quot;) by promoting collaborations between international scientific societies and institutions, and launching, in 2018, the revised European consensus on the definition and diagnosis on sarcopenia (EWGSOP2).1 We aim to prospectively evaluate the prevalence and incidence of sarcopenia (as defined by the EWGSOP2 criteria) in hospitalized patients across Europe (Belgium, Denmark, Germany, Italy, the Czech Republic, Poland, Portugal, Spain, and the United Kingdom) to assess risk factors associated with its presence or incidence and to assess sarcopenia-related adverse clinical outcomes.

Název v anglickém jazyce

Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+EAMA Project

Popis výsledku anglicky

Sarcopenia is a disease characterized by a progressive loss of skeletal muscle mass and strength and is related to physical impairment, disability, worse clinical outcomes, and mortality in all health care settings.1 An important fact is that it is also reversible, with tailored exercise and nutritional support.1,2 Sarcopenia prevalence varies widely depending on the criteria, measurement methods, and cut-off points used for its assessment1,2; to date, few studies addressed the issue of sarcopenia in hospitalized older patients, rendering it an under-recognized clinical entity.3-5 In 2015, the European Geriatric Medicine Society (EuGMS) founded the Special Interest Group on Sarcopenia, which aims to bridge the gaps between clinical practice and research (&quot;Action-Research Philosophy&quot;) by promoting collaborations between international scientific societies and institutions, and launching, in 2018, the revised European consensus on the definition and diagnosis on sarcopenia (EWGSOP2).1 We aim to prospectively evaluate the prevalence and incidence of sarcopenia (as defined by the EWGSOP2 criteria) in hospitalized patients across Europe (Belgium, Denmark, Germany, Italy, the Czech Republic, Poland, Portugal, Spain, and the United Kingdom) to assess risk factors associated with its presence or incidence and to assess sarcopenia-related adverse clinical outcomes.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30227 - Geriatrics and gerontology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the American Medical Directors Association

ISSN

1525-8610

e-ISSN

—

Svazek periodika

20

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

3

Strana od-do

"E1"-"E3"

Kód UT WoS článku

000493804900001

EID výsledku v databázi Scopus

2-s2.0-85074053523